CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market buy 10% owner bought 2,500,000 shares at $6.25 ($15,625,000)
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 4/A Insider Changes in Ownership
- 4 Grant or award Director acquired 9,689 shares (grant or award)
- 4 Grant or award Director acquired 3,673 shares (grant or award)
- 4 Grant or award Director acquired 1,065 shares (grant or award)
- 8-K Event Other events
- SC TO-T/A Deal Tender Offer Statement
- 4 Planned sale EVP, General Counsel sold 13,370 shares at $7.31 ($97,735)
- 144 Insider Sale of Securities
- DEF 14A Proxy Proxy Statement
- SC TO-T/A Deal Tender Offer Statement
Page 4 of 121 · 2,419 filings